Type 1 diabetes: treatment [sounds like]
182 results
1 - 100
Hormone replacement therapy for women with type 1 diabetes mellitus: Cochrane systematic review- Enhanced glucose control for preventing and treating diabetic neuropathy
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
- Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review
- Alpha‐lipoic acid for diabetic peripheral neuropathy
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Different insulin types and regimens for pregnant women with pre‐existing diabetes
- Exercise for pregnant women with pre‐existing diabetes for improving maternal and fetal outcomes
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Blood pressure control for diabetic retinopathy
- Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
- Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
- Fenofibrate for diabetic retinopathy
- Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Cinnamon for diabetes mellitus
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Psychological interventions for diabetes‐related distress in adults with type 2 diabetes mellitus
- Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
- Treatment of periodontitis for glycaemic control in people with diabetes mellitus
- Different lasers and techniques for proliferative diabetic retinopathy: Cochrane systematic review
- Glucose targets for preventing diabetic kidney disease and its progression
- Altered dietary salt intake for preventing diabetic kidney disease and its progression
- Dietary advice for the prevention of type 2 diabetes mellitus in adults: Cochrane systematic review
- Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Metformin monotherapy for adults with type 2 diabetes mellitus
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Intensive versus conventional glycaemic control for treating diabetic foot ulcers
- Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
- Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
- Silver based wound dressings and topical agents for treating diabetic foot ulcers
- Specialist nurses in diabetes mellitus: Cochrane systematic review
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes
- Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
- Pentoxifylline for diabetic kidney disease
- Peroxisome proliferator‐activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
- Insulin for the treatment of women with gestational diabetes
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews
- Ayurvedic treatments for diabetes mellitus: Cochrane systematic review
- Different strategies for diagnosing gestational diabetes to improve maternal and infant health
- Diabetes as a risk factor for tuberculosis disease
- Growth factors for treating diabetic foot ulcers
- Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
- Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings
- Colesevelam for type 2 diabetes mellitus
- Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
- Pressure-relieving interventions for treating diabetic foot ulcers: Cochrane systematic review
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: Cochrane systematic review
- Topical antimicrobial agents for treating foot ulcers in people with diabetes
- Spinal cord stimulation for chronic pain: Cochrane systematic review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
- Systemic antibiotics for treating diabetic foot infections
- Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- GLP‐1 receptor agonists for Parkinson's disease
- Gabapentin for chronic neuropathic pain in adults
- Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
- Vitamin B and its derivatives for diabetic kidney disease: Cochrane systematic review
- Psychological interventions for parents of children and adolescents with chronic illness